Paris IBD Center S.A.S.

The medical center is at the forefront of gastroenterology research, focusing on innovative treatments for inflammatory bowel diseases. The center's work on Ulcerative Colitis is particularly noteworthy, as it explores the safety and efficacy of novel therapeutic agents like PRA023.

• Ulcerative Colitis
• Crohn's Disease

By advancing the understanding of these conditions, the center contributes significantly to improving patient outcomes and quality of life.

In the field of neurology, the center is pioneering research into Relapsing Multiple Sclerosis (RMS). The focus is on evaluating the efficacy of treatments like IMU-838, which aim to delay relapses and enhance patient management strategies.

• Relapsing Multiple Sclerosis

This research is crucial in developing more effective therapies that can alter the course of neurological diseases and improve long-term patient care.